YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

AbbVie to buy Allergan for $63B

Posted online

AbbVie signed on to buy rival drugmaker Allergan for $63 billion.

The bid values Allergan's shares at a 45% premium.

The acquisition would combine AbbVie, the maker of arthritis drug Humira, and Allergan, which is known for its wrinkle treatment Botox, among other products.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
From the Ground Up: Roy Blunt Hall addition

Missouri State University’s science building, built in 1971 and formerly called Temple Hall, is being reconstructed and updated.

Most Read
Update cookies preferences